Details for New Drug Application (NDA): 017895
✉ Email this page to a colleague
NDA 017895 describes JANIMINE, which is a drug marketed by Abbott and is included in one NDA. Additional details are available on the JANIMINE profile page.
The generic ingredient in JANIMINE is imipramine hydrochloride. There are thirty-four drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the imipramine hydrochloride profile page.
The generic ingredient in JANIMINE is imipramine hydrochloride. There are thirty-four drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the imipramine hydrochloride profile page.
Summary for 017895
| Tradename: | JANIMINE |
| Applicant: | Abbott |
| Ingredient: | imipramine hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
